1. Home
  2. ASMB vs GUTS Comparison

ASMB vs GUTS Comparison

Compare ASMB & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • GUTS
  • Stock Information
  • Founded
  • ASMB 2005
  • GUTS 2010
  • Country
  • ASMB United States
  • GUTS United States
  • Employees
  • ASMB N/A
  • GUTS N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • GUTS
  • Sector
  • ASMB Health Care
  • GUTS
  • Exchange
  • ASMB Nasdaq
  • GUTS NYSE
  • Market Cap
  • ASMB 97.8M
  • GUTS 110.1M
  • IPO Year
  • ASMB 2010
  • GUTS 2024
  • Fundamental
  • Price
  • ASMB $15.21
  • GUTS $1.79
  • Analyst Decision
  • ASMB Buy
  • GUTS Buy
  • Analyst Count
  • ASMB 2
  • GUTS 2
  • Target Price
  • ASMB $35.00
  • GUTS $18.00
  • AVG Volume (30 Days)
  • ASMB 42.2K
  • GUTS 299.9K
  • Earning Date
  • ASMB 11-07-2024
  • GUTS 02-02-2025
  • Dividend Yield
  • ASMB N/A
  • GUTS N/A
  • EPS Growth
  • ASMB N/A
  • GUTS N/A
  • EPS
  • ASMB N/A
  • GUTS N/A
  • Revenue
  • ASMB $28,326,000.00
  • GUTS $97,000.00
  • Revenue This Year
  • ASMB $282.16
  • GUTS N/A
  • Revenue Next Year
  • ASMB N/A
  • GUTS N/A
  • P/E Ratio
  • ASMB N/A
  • GUTS N/A
  • Revenue Growth
  • ASMB N/A
  • GUTS N/A
  • 52 Week Low
  • ASMB $9.12
  • GUTS $1.74
  • 52 Week High
  • ASMB $19.93
  • GUTS $14.50
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 46.95
  • GUTS 36.46
  • Support Level
  • ASMB $13.20
  • GUTS $2.00
  • Resistance Level
  • ASMB $16.75
  • GUTS $2.13
  • Average True Range (ATR)
  • ASMB 1.05
  • GUTS 0.20
  • MACD
  • ASMB -0.08
  • GUTS -0.05
  • Stochastic Oscillator
  • ASMB 53.03
  • GUTS 4.76

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About GUTS FRACTYL HEALTH INC

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Share on Social Networks: